Inventor · disambiguated record
Trine Lindsted
Also filed as: LINDSTED TRINE
6 granted patents·4 pending applications·17 citations·filing 2010–2025
76Inventor score
Top patents by PatentIndex Score
10 records- 0186US7947653B1Methods for treating epidermal growth factor receptor tyrosine kinase inhibitor-resistant cancersCOLD SPRING HARBOR LAB·Filed 2011·Granted May 24, 2011·10 cites·8 claims
- 0285US11390674B2Anti-TIM-3 antibodies and compositionsSYMPHOGEN AS·Filed 2017·Granted Jul 19, 2022·4 cites·23 claims
- 0373US2024270848A1Combination therapies targeting pd-1, tim-3, and lag-3SERVIER LAB·Filed 2024·Application pending·0 cites
- 0471US11939380B2Combination therapies targeting PD-1, TIM-3, and LAG-3SYMPHOGEN AS·Filed 2018·Granted Mar 26, 2024·1 cites·16 claims
- 0567US2022380470A1Combination therapies targeting pd-1, tim-3, and lag-3SYMPHOGEN AS·Filed 2022·Application pending·0 cites
- 0662US8323883B1Methods of assessing therapeutic benefits of patients having cancers resistant to epidermal growth factor receptor kinase inhibitorsSORDELLA RAFFAELLA·Filed 2010·Granted Dec 4, 2012·2 cites·7 claims
- 0761US12252539B2Anti-FLT3 antibodies and compositionsSERVIER LAB·Filed 2021·Granted Mar 18, 2025·0 cites·14 claims
- 0854US11807688B2Anti-AXL antibodies and compositionsSYMPHOGEN AS·Filed 2021·Granted Nov 7, 2023·0 cites·19 claims
- 0953US2025179195A1Anti-flt3 antibodies and compositionsSERVIER LAB·Filed 2025·Application pending·0 cites
- 1048US2021214454A1Anti-cd40 antibodies and compositionsSYMPHOGEN AS·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Trine Lindsted files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →